ACE2 and COVID-19: Inactivation of the ACE2 complex leads to thrombosis in infected and noninfected tissues, aberrant sensory and neurological perception in COVID-19 patients and, most importantly, to necrosis in pulmonary, endothelial, and cardiac cells.